First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
Xu‐Han Zhang, Kaidi Song, Fei Tong, Mingming Fei, Hui Guo, Zhaohui Lu, Jinquan Wang, Changcheng Zheng
Abstract
Key Points We report the first case of coronavirus disease 2019 (COVID-19) in a multiple myeloma patient successfully treated with tocilizumab. Although tocilizumab was effective in the treatment of COVID-19 in this case, randomized controlled trials are needed.
Topics & Concepts
TocilizumabCoronavirus disease 2019 (COVID-19)Multiple myelomaMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CoronavirusInternal medicineVirologyOncologyDiseaseInfectious disease (medical specialty)OutbreakMultiple Myeloma Research and TreatmentsSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies